Table 1.
ANCA-associated vasculitides (AAV) | |
---|---|
Microscopic polyangiitis (MPA) | Chapel Hill Consensus Conference nomenclature [23] |
Wegener's granulomatosis (WG) | ACR Classification Criteria for WG [24] |
Churg-Strauss syndrome (CSS) | ACR Classification Criteria for CSS [25] |
Other vasculitides | |
Polyarteritis nodosa (PAN) | ACR Classification Criteria for PAN [26] |
Behçet's disease (BD) | International Criteria for BD [27] |
Henoch-Schönlein purpura (HSP) | ACR Classification Criteria for HSP [28] |
Cryoglobulinemic vasculitis | Chapel Hill Consensus Conference nomenclature [23] |
Secondary vasculitis | Diagnostic criteria of underlying disease, histological confirmation |
Undefined vasculitis | Clinical features without histological confirmation |
Gastrointestinal disorders (GD) | |
Inflammatory bowel disease (IBD) | Clinical, endoscopic, radiological and histological criteria [29] |
Primary sclerosing cholangitis | Clinical, radiological and immunological criteria [30] |
Autoimmune hepatitis (AIH) | International Criteria for AIH [31] |
Primary biliary cirrhosis | Clinical, biochemical, immunological and histological criteria [32] |
Connective tissue diseases (CTD) | |
Systemic lupus erythematosus (SLE) | Updated revised ACR Criteria for SLE [33] |
Rheumatoid arthritis (RA) | Revised ARA criteria for RA [34] |
Felty's syndrome | Clinical, radiological and laboratory criteria [35] |
Systemic sclerosis (SSc) | ARA preliminary classification Criteria for SSc [36] |
Dermatomyositis (DM) | Bohan and Peter diagnostic Criteria for DM [37, 38] |
Sjögren's syndrome (SjS) | Revised International Classification Criteria for SjS [39] |
Mixed connective tissue disease (MCTD) | Alarcon-Segovia Diagnostic Criteria for MCTD [40] |
Reiter's syndrome | Clinical, radiological and immunological criteria [41] |
Ankylosing spondylitis | Clinical, radiological and immunological criteria [42] |
Juvenile chronic arthritis | Clinical, radiological and immunological criteria [43] |
Relapsing polychondritis | Clinical, radiological and histological criteria [44] |
Psoriasis | Clinical features |
Antiphospholipid syndrome | Clinical and laboratory criteria [45] |
Rheumatic polymyalgia | Clinical features and laboratory findings |
Infections | |
Tuberculosis (TBC) | |
S. aureus (subacute endocarditis) | |
Other bacterial infections | Clinical features and laboratory findings |
AIDS | |
Hepatitis C | |
Aspergillosis | |
Renal diseases (RD) | |
Poststreptococcal nephropathy (PSGN) | |
IgA nephropathy | Laboratory and immunological findings, histological confirmation |
Goodpasture's disease | |
Membranous nephropathy | |
Malignancies | |
Carcinoma | |
Lymphoma | Clinical features, laboratory findings, histological confirmation |
Chronic myelocytic leukaemia | |
Myelodysplasia | |
Monoclonal gammopathies | |
Neurological disorders (ND) | |
Demyelinating disease Stroke |
Neurological symptoms and imaging findings |
Miscellaneous disorders | |
Sarcoidosis | Clinical features, laboratory and imaging findings |
Autoimmune hemolytic anemia (AHA) | Clinical features and laboratory findings |
Pulmonary fibrosis | Imaging findings, histological confirmation |
Medication | |
Antithyroid drugs | |
Allopurinol | History of medication treatment |
Phenytoin |